CLXN
Calaxin
Also known as: CLXN_HUMAN, EFCAB1, FLJ11767, ODAD5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HAE3
- Gene
- CLXN
- Ensembl
- ENSG00000034239
- Chromosome
- 8
- Canonical length
- 211 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mid piece,Principal piece
OverviewNCBI Gene
Predicted to enable calcium ion binding activity. Predicted to be involved in several processes, including cilium movement; outer dynein arm assembly; and regulation of flagellated sperm motility. Located in sperm flagellum. Implicated in primary ciliary dyskinesia. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
211 residues, UniProt reviewed canonical sequence.
>Q9HAE3|CLXN
1 MNRKKLQKLT DTLTKNCKHF NKFEVNCLIK LFYDLVGGVE RQGLVVGLDR NAFRNILHVT
61 FGMTDDMIMD RVFRGFDKDN DGCVNVLEWI HGLSLFLRGS LEEKMKYCFE VFDLNGDGFI
121 SKEEMFHMLK NSLLKQPSEE DPDEGIKDLV EITLKKMDHD HDGKLSFADY ELAVREETLL
181 LEAFGPCLPD PKSQMEFEAQ VFKDPNEFND MLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLXN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 86 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 86 nTPM
- choroid plexus: 51 nTPM
- testis: 36 nTPM
- ovary: 14 nTPM
- hippocampal formation: 12 nTPM
- endometrium: 12 nTPM
Single-cell type
- late spermatids: 736 nCPM
- early spermatids: 622 nCPM
- respiratory ciliated cells: 518 nCPM
- fallopian tube ciliated cells: 451 nCPM
- epididymal efferent duct ciliated cells: 348 nCPM
- ependymal cells: 268 nCPM
Immune cell
- neutrophil: 1.2 nTPM
- MAIT T-cell: 0.3 nTPM
- NK-cell: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
Brain region
- choroid plexus: 48 nTPM
- medulla oblongata: 31 nTPM
- midbrain: 27 nTPM
- spinal cord: 20 nTPM
- white matter: 18 nTPM
- hypothalamus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLXN.
Disease | AllUniProt
Conditions CLXN is implicated in, by any mechanism.
- Ciliary dyskinesia, primary, 53 (CILD53) MIM:620642
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 32 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ciliary dyskinesia, primary, 53
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium movement
- outer dynein arm assembly
- regulation of cilium movement
- regulation of flagellated sperm motility
- regulation of signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLXN as an antibody target. Whether an autoantibody or antibody against CLXN could matter depends on whether native CLXN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLXN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLXN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...